Skip to content

Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01145144
Enrollment
Unknown
Registered
2010-06-16
Start date
2008-01-31
Completion date
2009-07-31
Last updated
2010-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Stimulation

Keywords

Dehydroepiandrosterone, DHEA, IVF outcome, long protocol IVF, poor-responder, recombinant LH, embryo quality, pregnancy rate, live birth rate, poor response to ovarian stimulation

Brief summary

The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.

Interventions

DRUGdehydroepiandrosterone crystalline fine powder

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* previous poor response to ovarian stimulation in IVF.

Exclusion criteria

* patients over the age of 42 * patients who received DHEA at any time.

Design outcomes

Primary

MeasureTime frame
peak estradiol level.
number of retrieved oocytes.
Embryos that were graded as a top quality (according to the number of cells and percent of fragmentation)
number of embryos reserved for transfer.

Secondary

MeasureTime frame
pregnancy rate.
live birth rate.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026